Cytek Biosciences/CTKB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Cytek Biosciences

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.

Ticker

CTKB

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Wenbin Jiang

Employees

637

Headquarters

Fremont, United States

CTKB Metrics

BasicAdvanced
$739M
Market cap
-
P/E ratio
-$0.09
EPS
-
Beta
-
Dividend rate
$739M
$9.87
$3.80
710K
6.994
6.009
0.376
0.87
-2.26%
-2.82%
-2.54%
3.681
1.882
2.087
514.67
20.91%
-342.61%
27.63%

What the Analysts think about CTKB

Analyst Ratings

Majority rating from 6 analysts.
Buy

CTKB Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-13.61% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$45M
-23.02%
Net income
-$6.1M
-210.91%
Profit margin
-13.61%
-244.02%

CTKB Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 25.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.03
-$0.05
$0.04
-$0.05
-
Expected
$0.03
$0.03
$0.00
-$0.04
-$0.03
Surprise
-200.00%
-266.67%
1,100.12%
25.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Cytek Biosciences stock?

Cytek Biosciences (CTKB) has a market cap of $739M as of June 19, 2024.

What is the P/E ratio for Cytek Biosciences stock?

The price to earnings (P/E) ratio for Cytek Biosciences (CTKB) stock is 0 as of June 19, 2024.

Does Cytek Biosciences stock pay dividends?

No, Cytek Biosciences (CTKB) stock does not pay dividends to its shareholders as of June 19, 2024.

When is the next Cytek Biosciences dividend payment date?

Cytek Biosciences (CTKB) stock does not pay dividends to its shareholders.

What is the beta indicator for Cytek Biosciences?

Cytek Biosciences (CTKB) does not currently have a Beta indicator.

What is the Cytek Biosciences stock price target?

The target price for Cytek Biosciences (CTKB) stock is $9.5, which is NaN% below the current price of $. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Cytek Biosciences stock

Buy or sell Cytek Biosciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing